Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions)
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anticholinergic Bronchodilators Versus Beta2‐sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Anticholinergic_bronchodilators_versus_beta2‐sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed 30 January 2023.
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Anticholinergic_bronchodilators_versus_beta2‐sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed January 30, 2023.
Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Anticholinergic_bronchodilators_versus_beta2‐sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
Anticholinergic Bronchodilators Versus Beta2‐sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 January 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Anticholinergic_bronchodilators_versus_beta2‐sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease Edited (no change to conclusions)
ID - 439696
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439696/all/Anticholinergic_bronchodilators_versus_beta2‐sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -